Simurosertib hemihydrateProduct ingredient for Simurosertib

Show full entry for Simurosertib
Name
Simurosertib hemihydrate
Drug Entry
Simurosertib

Simurosertib is under investigation in clinical trial NCT03261947 (A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors).

See full entry for Simurosertib
Accession Number
DBSALT003280
Structure
Synonyms
2-[(2S)-1-azabicyclo[2.2.2]oct-2-yl]-6-(3-methyl-1H-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3H)-one hemihydrate
UNII
1E98KCJ6UB
CAS Number
2135874-50-7
Not Available
Predicted Properties
Not Available